3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Lymphoid
1
Conditions
Pain
4
Breast Neoplasms
4
Neoplasms
3
Anxiety Disorders
3
Multiple Myeloma
2
Fatigue
2
Carcinoma, Ovarian Epithelial
2
Wounds and Injuries
1
Vomiting
1
Urinary Bladder Neoplasms
1
Thrombocythemia, Essential
1
Stroke
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Sezary Syndrome
1
Sepsis
1
Recurrence
1
Pulmonary Disease, Chronic Obstructive
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Popliteal Cyst
1
Polycythemia Vera
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Parasomnias
1
Ovarian Neoplasms
1
Osteoarthritis, Knee
1
Nausea
1
Mycosis Fungoides
1
Melanoma
1
Interventions
Cyclophosphamide
282
Rituximab
260
Etoposide
161
Filgrastim
155
Vincristine
145
Doxorubicin
134
Prednisone
117
Cytarabine
108
Radiotherapy
102
Peripheral Blood Stem Cell Transplantation
90
Methotrexate
90
fludarabine phosphate
87
Melphalan
78
Busulfan
71
Dexamethasone
59
Granulocyte Colony-Stimulating Factor
56
Carmustine
53
fludarabine
51
Bortezomib
46
Tacrolimus
44
Mycophenolic Acid
41
Antilymphocyte Serum
41
Ifosfamide
40
Leucovorin
39
Gemcitabine
38
Whole-Body Irradiation
36
Cyclosporine
35
Bendamustine Hydrochloride
34
sargramostim
33
Methylprednisolone
32
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Lymphoma
×
Massage
×
Clear all
NCT06063603
2025-09-18
ASCENT
Mayo Clinic
Phase NA
Completed
51 enrolled
8 charts